Series C+ · 2026-11-17 · Healthcare
Isomorphic Labs raises $5.00B
88
AI Score
Amount
$5.00B
Round
Series C+
Lead
Greenoaks, Sequoia
HQ
GB
Why it matters: The round comes six months after a $2.1bn Series B, showing how much capital investors are willing to put behind AI-driven drug discovery before any candidate reaches clinical trials.
Isomorphic Labs, the London drug discovery company spun out of Google DeepMind, raised a $5bn Series C co-led by Sequoia and Greenoaks.
- Participants:
- Andreessen Horowitz, Thrive Capital, Alphabet, GV, CapitalG, Tamesek, Sovereign AI fund
- Source:
- Tech.eu ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Isomorphic Labs
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
More deals with Greenoaks
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing